Huadong Medicine Co Ltd
SZSE:000963
Huadong Medicine Co Ltd
Operating Income
Huadong Medicine Co Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Huadong Medicine Co Ltd
SZSE:000963
|
Operating Income
¥3.7B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
15%
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Operating Income
¥22.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
16%
|
|
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Operating Income
¥8.9B
|
CAGR 3-Years
5%
|
CAGR 5-Years
9%
|
CAGR 10-Years
12%
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Operating Income
¥3.9B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
11%
|
CAGR 10-Years
18%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Operating Income
¥2.4B
|
CAGR 3-Years
16%
|
CAGR 5-Years
5%
|
CAGR 10-Years
21%
|
C
|
China National Accord Medicines Corp Ltd
SZSE:000028
|
Operating Income
¥2.4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
10%
|
CAGR 10-Years
12%
|
See Also
What is Huadong Medicine Co Ltd's Operating Income?
Operating Income
3.7B
CNY
Based on the financial report for Sep 30, 2023, Huadong Medicine Co Ltd's Operating Income amounts to 3.7B CNY.
What is Huadong Medicine Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
15%
Over the last year, the Operating Income growth was 18%. The average annual Operating Income growth rates for Huadong Medicine Co Ltd have been 5% over the past three years , 6% over the past five years , and 15% over the past ten years .